Holdings of Kynam Capital Management, LP

Name: Holdings of Kynam Capital Management, LP
Creator: Titelia
License: https://titelia.com/en/sources

Portfolio shape

Positions

Rank	Company	Shares	Value
1	Syndax Pharmaceuticals Inc	8,050,959	188.1M $
2	Celldex Therapeutics Inc	5,840,567	185.3M $
3	Vaxcyte Inc	2,922,335	169.8M $
4	Cogent Biosciences Inc	4,037,331	155.4M $
5	Vera Therapeutics Inc	3,398,224	136.7M $
6	Beam Therapeutics Inc	3,682,185	87.7M $
7	CytomX Therapeutics Inc	15,013,093	70.6M $
8	BioCryst Pharmaceuticals Inc	5,680,795	54.1M $
9	Travere Therapeutics Inc	1,569,018	46.6M $
10	Viridian Therapeutics Inc	2,341,652	45.8M $
11	Cullinan Therapeutics Inc	3,114,132	44.3M $
12	KalVista Pharmaceuticals Inc	1,820,954	36.7M $
13	Apellis Pharmaceuticals Inc	825,000	33.2M $
14	LEGEND BIOTECH CORP	1,576,295	28.5M $
15	MBX Biosciences Inc	934,799	27.9M $
16	Immunocore Holdings PLC	884,937	26.7M $
17	Sutro Biopharma Inc	872,558	21.7M $
18	Burning Rock Biotech Ltd	1,227,555	19.8M $
19	Soleno Therapeutics Inc	560,000	18.7M $
20	Nurix Therapeutics Inc	1,194,757	18.5M $
21	Evommune Inc	625,496	14.4M $
22	Relay Therapeutics Inc	1,424,259	14.2M $
23	Geron Corp	6,836,318	10.2M $
24	Design Therapeutics Inc	784,606	8.3M $
25	Climb Bio Inc	1,003,341	6.9M $
26	Amarin Corp PLC	472,382	6.8M $
27	Prelude Therapeutics Inc	1,592,551	5.4M $
28	Caribou Biosciences Inc	2,503,302	4.8M $
29	Alector Inc	2,000,000	4.3M $
30	Candel Therapeutics Inc	200,000	980K $

Download this table: CSV, JSON

Titelia classification, company by company. The unattributed share stays visible.

The quoted currency of each line, as declared.

Shares computed on the equity sleeve.

Rank	Country	Lines	Value	Share
1	United States	27	1.4B $	96.31 %
2	Cayman Islands	2	48.3M $	3.24 %
3	United Kingdom	1	6.8M $	0.46 %

Cite this page

Titelia. "Holdings of Kynam Capital Management, LP". https://titelia.com/en/funds/US13F1907884